Washington, D.C. 20549






Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of June, 2023

Commission File Number 001-39670




(Translation of registrant’s name into English)



6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive office)



Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐





On May 9, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) announced the commencement of a $50 million share repurchase program (the “Program”) of its ordinary shares of one pence each (“Ordinary Shares”). The Company plans to execute the Program in two equal tranches, the first of which was completed on October 26, 2022. In respect of each of the two tranches, PureTech entered into an irrevocable non-discretionary instruction with Jefferies International Limited (“Jefferies”) in relation to the purchase by Jefferies of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Ordinary Shares by Jefferies to PureTech. Jefferies makes its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject. Any purchase of Ordinary Shares under the second tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with, and subject to limits, including those limits related to daily volume and price, prescribed by the Company’s general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting on June 13, 2023, Chapter 12 of the Financial Conduct Authority’s UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). All Ordinary Shares repurchased under the Program will be held in treasury.

During the month ended June 30, 2023, the Company had the following daily purchases of its own Ordinary Shares under the Program through Jefferies:



   Ordinary Shares
     Volume Weighted
Average Price Paid
per Ordinary Share
     Highest Price Paid      Lowest Price Paid  

June 1, 2023

     43,475        219.45p        222.50p        215.00p  

June 2, 2023

     47,401        224.26p        229.00p        219.00p  

June 5, 2023

     17,052        234.45p        234.50p        232.50p  

June 6, 2023

     47,846        235.75p        236.50p        234.50p  

June 7, 2023

     48,641        236.88p        238.50p        233.50p  

June 8, 2023

     48,064        239.73p        241.00p        236.00p  

June 9, 2023

     49,317        241.00p        243.50p        237.50p  

June 12, 2023

     49,134        237.99p        240.00p        234.50p  

June 13, 2023

     45,779        237.89p        240.00p        235.50p  

June 14, 2023

     48,839        234.64p        237.00p        233.00p  

June 15, 2023

     52,481        234.02p        236.50p        232.00p  

June 16, 2023

     53,031        235.80p        238.00p        234.00p  

June 19, 2023

     54,956        234.07p        235.50p        231.00p  

June 20, 2023

     54,341        232.72p        234.00p        230.00p  

June 21, 2023

     47,446        232.43p        234.50p        231.00p  

June 22, 2023

     47,690        229.03p        231.50p        225.00p  

June 23, 2023

     51,593        230.40p        232.00p        227.00p  

June 26, 2023

     53,442        224.91p        231.50p        221.50p  

June 27, 2023

     53,920        221.15p        224.00p        218.50p  

June 28, 2023

     53,656        226.83p        229.50p        220.50p  

June 29, 2023

     52,077        222.37p        227.00p        218.50p  

June 30, 2023

     52,348        219.50p        220.50p        217.00p  

During the month ended June 30, 2023, the Company repurchased an aggregate of 1,072,529 Ordinary Shares. As of June 30, 2023, the Company’s issued share capital was 289,468,159 shares, 12,795,330 of which were held in treasury, resulting in total voting rights in the Company of 276,672,829 shares. To view the details of the individual transactions, please paste the following URL(s) into the address bar of your browser with respect to each individual date of repurchase under the Program:

June 1, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4789482.html

June 2, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4790970.html

June 5, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4792499.html

June 6, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4793981.html

June 7, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4795454.html

June 8, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4797063.html

June 9, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4798471.html

June 12, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4799962.html

June 13, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4801421.html

June 14, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4802958.html

June 15, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4804476.html

June 16, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4805994.html

June 19, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4807445.html

June 20, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4808902.html

June 21, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4810436.html

June 22, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4811896.html

June 23, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4813370.html

June 26, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4814930.html

June 27, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4816437.html

June 28, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4818332.html

June 29, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4819933.html

June 30, 2023: https://data.fca.org.uk/artefacts/NSM/RNS/4821724.html


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: July 6, 2023     By:   /s/ Daphne Zohar
      Name:   Daphne Zohar
      Title:   Chief Executive Officer